
Alnylam and Inceptive land up to $2 billion AI RNA deal
The pact could speed RNA drug discovery, showing how AI is becoming a core tool in biotech dealmaking, not just a lab experiment.
By Mohammed Al-Shehri·· 3 min
1 briefing · “inceptive”

The pact could speed RNA drug discovery, showing how AI is becoming a core tool in biotech dealmaking, not just a lab experiment.